Effects of Siwei Yuganzi decoction on LXRα and CYP7A1 in hyperlipidemic rats
Journal Title: Traditional Medicine Research - Year 2019, Vol 4, Issue 6
Abstract
Highlights A Tibetan (one of the ethnic minorities in China) compound preparation, Siwei Yuganzi decoction, can improve the serum levels of TC, TG, and LDL-C in the hyperlipidemic animal model via increasing the expression of both LXRα and CYP7A1 mRNA and proteins in the liver tissue. Traditionality Siwei Yuganzi decoction is an adaptation of a classical prescription of the Tibetan medicine called Sanguo decoction, which is recorded in the classic ancient book of Tibetan medicine entitled Sibu Jingdian, written by the famous Tibetan medical scientist named G.yuthog Rnyingma·Yontan Mgonpo in 800 C.E.. Abstract Background: Hyperlipidemia (HLP) is a disorder in which lipids in the blood are disturbed due to abnormal lipid metabolism. Statins and fibrates lipid-regulating drugs prevent the generation of lipids and improves HLP, thereby reducing the likelihood of developing cardiovascular and cerebrovascular diseases. However, their adverse reactions and side effects limit a wide range of clinical applications. Tibetan medicine compound preparation Siwei Yuganzi decoction (SYD) is an adaptation of a classical prescription of the Tibetan medicine Sanguo decoction, that has been proved to have the effect of improving lipid metabolism; however, its possible mechanism remains unknown. Methods: Sixty specific-pathogen free grade Sprague Dawley rats were randomly divided into the blank control group, the HLP group, the Chinese patent medicine Xuezhikang positive control group, and the treatment groups with Tibetan SYD high-, middle-, and low-dosages respectively. Ten rats were assigned to each group. Every rat in these groups was fed with a high-fat emulsion to establish the hyperlipidemic animal model, except for those in the blank control group. Then the rats in the blank control and HLP groups were fed with 0.9% normal saline, those in Xuezhikang group were fed with Xuezhikang suspension at the dose of 0.11 g/kg/d, and those in SYD groups were fed with the SYD suspension at the dosage of 16.2 g/kg/d (high dosage), 10.8 g/kg/d (middle dosage), and 5.4 g/kg/d (low dosage), respectively. After 8 weeks, the levels of serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were detected by the ELISA. The mRNA and protein expression levels of liver X receptor α (LXRα) and cholesterol 7α-hydroxylase 1 (CYP7A1) were detected using RT-PCR, western blotting, and immunohistochemistry. Results: The serum levels of TC, TG, and LDL-C in the HLP group were higher than those in the blank control group (P < 0.05), whereas the serum levels of HDL-C and the expression levels of both LXRα and CYP7A1 mRNA and proteins in the liver in the HLP group were lower than those in the control group (P < 0.05). After the treatment of the Xuezhikang and SYD, the serum levels of TG, TC, and LDL-C significantly decreased (P < 0.05), whereas the serum levels of HDL-C and the expression levels of both LXRα and CYP7A1 mRNA and proteins in the liver significantly increased compared with those in the HLP group (P < 0.05). Furthermore, The serum levels of TC, TG, and LDL-C in the SYD group at high dosage were lower (P < 0.05), the serum level of HDL-C was higher, and the expression levels of both LXRα and CYP7A1 mRNA and proteins in the liver tissue were higher than those in the Xuezhikang group (P < 0.05). Conclusion: SYD can improve the serum levels of TC, TG, and LDL-C in the hyperlipidemic animal model via increasing the expression of both LXRα and CYP7A1 mRNA and proteins in the liver tissue.
Authors and Affiliations
Ru-Yi Yang, Hong-Bin Wang, Pan-Pan Zhou
Keywords
Related Articles
- EP ID EP482098
- DOI 10.12032/TMR20191024142
- Views 271
- Downloads 0
A network pharmacology approach to investigate the mechanisms of Si-Jun-Zi decoction in the treatment of gastric precancerous lesions
Objective: To find out the potential mechanisms of Si-Jun-Zi (SJZ) decoction in the treatment of gastric precancerous lesions (GPL). Methods: A network pharmacology approach was used to analyze the active compounds, drug...
Overview of the plague in the late Ming Dynasty and its prevention and control measures
The plague of the late Ming Dynasty (1551-1644 C.E.) was long lasting, affected a wide range of the population, and had serious consequences. The purpose of this study is to review the medical system in place at the time...
Modulation by anti-oketsu formulations in Kampo medicine of human arterial stiffness
Objective: In traditional herbal medicine (Kampo medicine in Japan), “sho” is diagnosed by the traditional assessments of clinical conditions. Among a variety of the shos, there is an “oketsu” syndrome, which is a stagna...
A multi-center randomized controlled clinical trial of three-step acupuncture and cupping therapy for cervicogenic headache
Objective: To assess the clinical efficacy and safety of three-step acupuncture and cupping therapy for cervicogenic headache (CEH). Methods: A randomized, single-blind, multi-center, parallel controlled clinical trial w...
Massage for migraine: A meta-analysis
Objective:This systematic review examined whether massage interventions provided any measurable benefit in migraine disorders. Methods:Randomized controlled trials (RCTs) were searched for in Cochrane Library, PubMed, We...